0000899243-22-004132.txt : 20220202
0000899243-22-004132.hdr.sgml : 20220202
20220202160543
ACCESSION NUMBER: 0000899243-22-004132
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220131
FILED AS OF DATE: 20220202
DATE AS OF CHANGE: 20220202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Buckle Isabelle
CENTRAL INDEX KEY: 0001823186
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36415
FILM NUMBER: 22583623
MAIL ADDRESS:
STREET 1: C/O QUOTIENT LIMITED, B1, BUSINESS PARK
STREET 2: TERRE BONNE, ROUTE DE CRASSIER 13
CITY: EYSINS
STATE: V8
ZIP: 1262
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quotient Ltd
CENTRAL INDEX KEY: 0001596946
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 264719797
STATE OF INCORPORATION: Y9
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 28 ESPLANADE
CITY: SAINT HELIER
STATE: Y9
ZIP: JE2 3QA
BUSINESS PHONE: 41274832286
MAIL ADDRESS:
STREET 1: 28 ESPLANADE
CITY: SAINT HELIER
STATE: Y9
ZIP: JE2 3QA
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-31
0
0001596946
Quotient Ltd
QTNT
0001823186
Buckle Isabelle
C/O QUOTIENT LIMITED, B1, BUSINESS PARK
TERRE BONNE, ROUTE DE CRASSIER 13
EYSINS
V8
1262
SWITZERLAND
1
0
0
0
Ordinary Shares
2022-01-31
4
S
0
1961
D
24499
D
Ordinary Shares
2022-01-31
4
M
0
6917
A
26460
D
Ordinary Share Option (Right to Buy)
4.81
2030-09-01
Ordinary Shares
20790
20790
D
Ordinary Share Option (Right to Buy)
4.81
2030-09-01
Ordinary Shares
2171
2171
D
Ordinary Share Option (Right to Buy)
4.55
2030-10-31
Ordinary Shares
13611
13611
D
Restricted Stock Units
2022-01-31
4
M
0
6917
0.00
D
Ordinary Shares
6917
20751
D
Ordinary Share Option (Right to Buy)
2.53
2031-10-31
Ordinary Shares
24040
24040
D
Restricted Stock Units convert into ordinary shares on a one-for-one basis.
6,930 options vested on September 1, 2021 and remain exercisable, and the remaining 13,860 options will vest in two equal installments on September 1, 2022 and September 2, 2023.
724 options vested on October 31, 2021 and remain exercisable, and the remaining 723 options will vest on October 31, 2022.
All 13,611 options have vested and remain exercisable.
On October 31, 2021, the Reporting Person was granted 27,668 restricted stock units, of which 6,917 have vested and have converted into ordinary shares. The remaining 20,751 restricted stock units will vest in three equal installments on April 30, 2022, July 31, 2022 and October 31, 2022.
The options vest and become exercisable on October 31, 2022.
The sale reported on this Form 4 is a sale to cover taxes arising from the vesting and settlement of RSU awards. This sale is mandated by the Reporting Person's election to fund such taxes by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer.
/s/ Isabelle Buckle
2022-02-02